Ticker
$CLVT
1 catalyst touching CLVT in the last 60 days, newest first, each with the price move that followed.
- 72
Clarivate completes $600M sale of Life Sciences unit to Altaris
Clarivate closed the sale of its Life Sciences and Healthcare business to Altaris for $500M in cash plus a $75M senior note and $25M in deferred consideration, totaling $600M. This is a material asset disposition that reduces CLVT's business footprint but generates significant liquidity for debt reduction or strategic reinvestment.
CLVT ▲SEC 8-K · 6 Oct 2026, 20:29 UTC
Information only. AURA does not give buy or sell recommendations.